AUTUMN MCGEE: Open Payments
NPI 1710345640 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,000 in 82 payments from 22 companies in 2025. Trend: 2023 $1,040 · 2024 $1,678 · 2025 $2,000
Food & beverage: $2,000
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $408 |
| Novo Nordisk Inc | 19 | $373 |
| PFIZER INC. | 11 | $210 |
| Abbott Laboratories | 2 | $167 |
| Lilly USA, LLC | 10 | $115 |
| CeQur Corporation | 1 | $85 |
| Astellas Pharma US Inc | 3 | $62 |
| Amgen Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| GlaxoSmithKline, LLC. | 3 | $57 |
Products named: Ozempic, TRICLIP, BREZTRI, Wegovy, FASENRA, JARDIANCE, AIRSUPRA, CeQur Simplicity.
Industry payments across TN — which companies pay providers there.
